Ferroptosis regulation of GLS2 as a potential therapeutic strategy against liver diseases

A new editorial paper was published in Oncotarget’s Volume 14 on October 19, 2023, entitled, “GLS2 shapes ferroptosis in hepatocellular carcinoma.”

Psychostimulant No Help in Relieving Cancer-Related Fatigue

Six weeks of treatment with methylphenidate did no better than placebo for improving cancer-related fatigue (CRF). The results continued a pattern of inconsistency in outcomes

May 23, 2024

Scoop: Eli Lilly agrees to acquire another European ADC biotech

Eli Lilly has agreed to acquire another antibody-drug conjugate biotech, swooping in for France-based Mablink Bioscience, Endpoints News has learned. The Sofinnova-backed startup is a

October 18, 2023

Review explores potential for improved use of anti-angiogenic agents in cancer therapy

Most tumors release various signaling molecules to support their incessant growth, invasion, and metastasis.

August 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.